New from the biotech pipeline: FDA turmoil overshadows 2025 approvals

Nature Biotechnology, Printed online: 19 January 2026; doi:10.1038/s41587-025-02994-1Leadership adjustments, group cuts and a raft of contemporary policies marked an agency in transition. Unusual drug approvals featured more discover-on merchandise than firsts…
Be taught More